The post DOGE retains greater market depth than BTC appeared on BitcoinEthereumNews.com. Dogecoin (DOGE) retained a surprisingly high liquidity. The market depthThe post DOGE retains greater market depth than BTC appeared on BitcoinEthereumNews.com. Dogecoin (DOGE) retained a surprisingly high liquidity. The market depth

DOGE retains greater market depth than BTC

For feedback or concerns regarding this content, please contact us at [email protected]

Dogecoin (DOGE) retained a surprisingly high liquidity. The market depth for the meme coin is around twice as high as for BTC. 

Dogecoin (DOGE) remains one of the most liquid assets, not only among meme tokens and coins. Compared to BTC, DOGE has a greater market depth, according to recent Kaiko research. 

Market depth is the main metric for slippage, and is closely watched to gauge eventual corrections. BTC stalled just below $73,000, once again raising concerns about selling pressure. 

DOGE retains liquidity even after the October 10 crash

According to Kaito research, the crypto market saw major shifts in available liquidity. DOGE held up surprisingly well, both in comparison to altcoins and to BTC. Kaito noted that DOGE increased its market depth after the October market crash, going against the market trend. 

DOGE book depth recovered quickly in 2026, according to Kaito research. According to the latest gauges, on average, DOGE 1% market depth sits around $13M, while BTC 1% market depth is at around $6M. 

Liquidity conditions may vary and change quickly, but DOGE shows it has not turned into a dead asset. DOGE still traded with much lower volumes compared to BTC and ETH, but was widely distributed on exchanges, tapping multiple global markets. 

DOGE is also a mined coin, adding to its longevity and resilience. Litecoin and Dogecoin mining rate is now close to its highest level in the past three months. 

Did a DOGE ETF boost market liquidity?

DOGE performed with great resilience in the past five months, contrary to the overall market sentiment. One of the reasons was the approval of DOGE ETF, which boosted inflows. 

Currently, there are four live DOGE ETFs and two more pending. The funds have a relatively low level of assets under management, but still managed to attract buying even during the market downturn. 

DOGE open interest also increased in the past few days, rising to over $445M, from a recent low of $353M. 

DOGE remained around a three-month low of $0.09. Despite this, the coin has seen some short-term rallies. Historically, DOGE has gone through significant breakouts and surges in interest. 

In early 2026, DOGE transactions are down to all-time lows of around 24K per day. During active periods, DOGE has handled over 2M daily transfers. Currently, the DOGE network carries around 50K daily active wallets. 

One big boost for DOGE may be the introduction of payments through X. DOGE has been promised to become the asset for micropayments, though adoption has lagged despite Elon Musk’s promises.

Source: https://www.cryptopolitan.com/doge-retains-greater-market-depth-than-btc/

Market Opportunity
DOGE Logo
DOGE Price(DOGE)
$0.09035
$0.09035$0.09035
+0.09%
USD
DOGE (DOGE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09